Abstract
Menopause-associated asthma is a subtype of asthma that is still largely unexplored and difficult to manage. Women experiencing menopause-associated asthma often have more severe exacerbations, higher rates of exacerbation, and most importantly, poor response to standard treatments. This study examined the impact of estrogen replacement given during the perimenopause phase on lung inflammation and function after menopause. While decreasing eosinophil recruitment, estrogen replacement actually led to worse lung function and more airway remodeling.
Funding Information
  • National Heart, Lung, and Blood Institute (HL142769)
  • National Institute on Aging (AG058503)
  • National Institute of Environmental Health Sciences (ES007091)

This publication has 53 references indexed in Scilit: